OverviewSuggest Edit

IQVIA Holdings is a company that provides analytics, technology solutions, and contract research services. It focuses on a range of life science-related industries, including biopharma, MedTech, generics, consumer health, etc. The company was formed as a result of a merger between IMS Health and Quintiles.
TypePublic
Founded2016
HQDanbury, CT, US
Websiteiqvia.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Mar 2021)72,000(+3%)
Job Openings8,053
Revenue (FY, 2020)$11.4 B(+3%)
Share Price (Jul 2021)$249.1(+2%)
Cybersecurity ratingCMore

Key People/Management at IQVIA

Ari Bousbib

Ari Bousbib

Chairman and Chief Executive Officer
Ron Bruehlman

Ron Bruehlman

Executive Vice President and Chief Financial Officer
Nick Childs

Nick Childs

Senior Vice President, Investor Relations and Corporate Communications
Trudy Stein

Trudy Stein

Executive Vice President and Chief Human Resources Officer
Karl Guenault

Karl Guenault

Senior Vice President and Chief Information Officer
Jim Berkshire

Jim Berkshire

Senior Vice President, Business Operations
Show more

IQVIA Office Locations

IQVIA has offices in Danbury, Durham, Hydra, Buenos Aires and in 104 other locations
Danbury, CT, US (HQ)
83 Wooster Heights
Durham, NC, US
4820 Emperor Blvd
Hydra, DZ
Cité Sellier, Coopérative Immobilière Mohamed Boudiaf N°18, 1er étage
Buenos Aires, AR
7° piso, Av. Leandro N. Alem 1050
Melbourne, AU
Level 2/606 St Kilda Rd
Sydney, AU
Level 8, 201 Pacific Highway St Leonards
Show all (118)

IQVIA Financials and Metrics

IQVIA Revenue

Embed Graph
View revenue for all periods
IQVIA's revenue was reported to be $11.36 b in FY, 2020 which is a 2.4% increase from the previous period.
USD

Revenue (Q1, 2021)

3.4b

Gross profit (Q1, 2021)

1.1b

Gross profit margin (Q1, 2021), %

32.7%

Net income (Q1, 2021)

217.0m

EBIT (Q1, 2021)

342.0m

Market capitalization (23-Jul-2021)

47.7b

Closing stock price (23-Jul-2021)

249.1

Cash (31-Mar-2021)

2.3b

EV

58.0b
IQVIA's current market capitalization is $47.7 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

10.4b11.1b11.4b

Revenue growth, %

7%6%2%

Cost of goods sold

6.7b7.3b7.5b

Gross profit

3.7b3.8b3.9b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

2.7b2.7b2.8b2.8b2.5b2.8b3.4b

Cost of goods sold

1.7b1.8b1.9b1.8b1.7b1.8b2.3b

Gross profit

936.0m941.0m917.0m930.0m817.0m986.0m1.1b

Gross profit Margin, %

35%34%33%34%32%35%33%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

891.0m837.0m1.8b

Accounts Receivable

2.4b2.6b2.4b

Prepaid Expenses

151.0m138.0m159.0m

Current Assets

3.9b4.1b5.1b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

936.0m938.0m863.0m927.0m1.1b1.5b2.3b

Accounts Receivable

2.5b2.4b2.5b2.6b2.4b2.4b2.4b

Prepaid Expenses

153.0m180.0m150.0m173.0m146.0m165.0m159.0m

Current Assets

4.0b4.0b4.0b4.3b4.2b4.6b5.6b
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

284.0m227.0m308.0m

Depreciation and Amortization

1.1b1.2b1.3b

Accounts Payable

368.0m240.0m253.0m

Cash From Operating Activities

1.3b1.4b2.0b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

67.0m138.0m207.0m91.0m70.0m178.0m217.0m

Depreciation and Amortization

295.0m589.0m888.0m316.0m624.0m943.0m323.0m

Cash From Operating Activities

113.0m504.0m834.0m163.0m635.0m1.2b867.0m

Purchases of PP&E

(141.0m)(296.0m)(445.0m)(141.0m)(283.0m)(440.0m)(149.0m)
USDFY, 2018

EV/EBIT

44.7 x

EV/CFO

26.4 x

Revenue/Employee

179.5k

Debt/Equity

1.6 x

Debt/Assets

0.5 x

Financial Leverage

3.2 x

P/E Ratio

93.7
Show all financial metrics

IQVIA Operating Metrics

IQVIA's Customers was reported to be 10 k in FY, 2020.
FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Healthcare Workers

14 m15 m16 m20 m22 m

Countries

828384100100

Customers

5 k8 k8 k8 k10 k

Data Sources

100 k120 k140 k150 k150 k
Show all operating metrics

IQVIA Acquisitions / Subsidiaries

Company NameDateDeal Size
Q2 SolutionsApril 01, 2021
LinguamaticsFebruary 12, 2019
Advanced Health Media LLCMay 31, 2018
DrugDevNovember 16, 2017
Aileron SolutionsJuly 01, 2014
Novella Clinical LLCAugust 14, 2013
159 SOLUTIONS
159 Technology Solutions Private Ltd
Advanced Health Media Services
AHM Global Operations Inc.
Show more

IQVIA Revenue Breakdown

Embed Graph

IQVIA revenue breakdown by business segment: 42.8% from Technology & Analytics Solutions, 50.7% from Research & Development Solutions and 6.5% from Contract Sales & Medical Solutions

IQVIA revenue breakdown by geographic segment: 32.5% from Europe and Africa, 47.7% from Americas and 19.8% from Asia-Pacific

IQVIA Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

IQVIA Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

IQVIA Online and Social Media Presence

Embed Graph

IQVIA News and Updates

IQVIA reveals integration of digital health tools into mainstream medicine

Digital health tools are increasingly having a positive impact on health outcomes. Some are becoming integral parts of mainstream medicine, according to findings released by the IQVIA Institute for Human Data Science in a new report, Digital Health Trends 2021: Innovation, Evidence, Regulation, and …

IQVIA Reports First-Quarter Results; Raises Full-Year 2021 Guidance

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2021.

Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK

Q2 Solutions, a leading global clinical trial laboratory services organization and a wholly owned subsidiary of IQVIA, has announced the expansion of its laboratory and operational capabilities at its Alba Campus in Livingston, Scotland. This expansion of central labs, genomics, flow cytometry, and …

nView Health Announces Multi-year License Agreement with IQVIA

nView Health, the premier provider of evidence-based behavioral health assessment solutions, is pleased to announce that is has executed a multi-year license agreement with IQVIA, one of the world's leading clinical research organizations. Under the terms of the Agreement, IQVIA will have access to …

Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science

Despite the substantial impact of the COVID-19 pandemic on patient care during 2020, the scientific advances in oncology continued, with 3,500 new drugs in the pipeline in 2020, up 75 percent since 2015. Oncologists worldwide report caseloads that are 26 to 51 percent lower than pre-pandemic levels,…

IQVIA Covid19 healthcare app challenge

IQVIA has announced details surrounding the COVID-19 Healthcare App Challenge, a hackathon-style competition for developers that wish to leverage the recently released IQVIA HealthCare Locator Software Development Kit. Starting today, developers can sign up for the hackathon here and will have until…
Show more

IQVIA Frequently Asked Questions

  • When was IQVIA founded?

    IQVIA was founded in 2016.

  • Who are IQVIA key executives?

    IQVIA's key executives are Ari Bousbib, Ron Bruehlman and Nick Childs.

  • How many employees does IQVIA have?

    IQVIA has 72,000 employees.

  • What is IQVIA revenue?

    Latest IQVIA annual revenue is $11.4 b.

  • What is IQVIA revenue per employee?

    Latest IQVIA revenue per employee is $157.8 k.

  • Who are IQVIA competitors?

    Competitors of IQVIA include Nielsen, McKinsey and Infosys.

  • Where is IQVIA headquarters?

    IQVIA headquarters is located at 83 Wooster Heights, Danbury.

  • Where are IQVIA offices?

    IQVIA has offices in Danbury, Durham, Hydra, Buenos Aires and in 104 other locations.

  • How many offices does IQVIA have?

    IQVIA has 118 offices.